MX9101391A - Composicion farmaceutica en forma de gel,contenida dentro de un envase - Google Patents

Composicion farmaceutica en forma de gel,contenida dentro de un envase

Info

Publication number
MX9101391A
MX9101391A MX919101391A MX9101391A MX9101391A MX 9101391 A MX9101391 A MX 9101391A MX 919101391 A MX919101391 A MX 919101391A MX 9101391 A MX9101391 A MX 9101391A MX 9101391 A MX9101391 A MX 9101391A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
gel
container
contained
pharmaceutical
Prior art date
Application number
MX919101391A
Other languages
English (en)
Inventor
Pierre Tachon
Beatrice Vagneur
Jean Louis Viret
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX9101391A publication Critical patent/MX9101391A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MX919101391A 1990-10-04 1991-10-01 Composicion farmaceutica en forma de gel,contenida dentro de un envase MX9101391A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90118920 1990-10-04

Publications (1)

Publication Number Publication Date
MX9101391A true MX9101391A (es) 1992-04-01

Family

ID=8204572

Family Applications (1)

Application Number Title Priority Date Filing Date
MX919101391A MX9101391A (es) 1990-10-04 1991-10-01 Composicion farmaceutica en forma de gel,contenida dentro de un envase

Country Status (27)

Country Link
US (2) US5300302A (es)
EP (1) EP0479005B1 (es)
JP (1) JP3219799B2 (es)
KR (1) KR100213513B1 (es)
AT (1) ATE131039T1 (es)
AU (1) AU643067B2 (es)
BR (1) BR9104280A (es)
CA (1) CA2052615C (es)
DE (1) DE69115210T2 (es)
DK (1) DK0479005T3 (es)
DZ (1) DZ1530A1 (es)
EG (1) EG19906A (es)
ES (1) ES2081407T3 (es)
FI (1) FI104947B (es)
GR (1) GR3018893T3 (es)
HU (1) HU219222B (es)
IE (1) IE72146B1 (es)
IL (1) IL99509A (es)
MA (1) MA22289A1 (es)
MX (1) MX9101391A (es)
MY (1) MY107488A (es)
NO (1) NO303525B1 (es)
NZ (1) NZ240068A (es)
PT (1) PT99143B (es)
RU (1) RU2093143C1 (es)
TN (1) TNSN91085A1 (es)
ZA (1) ZA917627B (es)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
JPH06172189A (ja) * 1992-08-17 1994-06-21 Bristol Myers Squibb Co 胃腸保護複合剤
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
AU3896395A (en) * 1994-10-11 1996-05-02 James A. Monson Dispensing apparatus for foaming compositions and method
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CA2262595C (en) * 1996-08-15 2005-10-18 Losan Pharma Gmbh Easy to swallow oral medicament composition
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6071523A (en) 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
KR100399483B1 (ko) * 2000-12-12 2003-09-29 대화제약 주식회사 플로로글루시놀을 유효성분으로 함유하는 신규 진경액제
CN1523979A (zh) * 2001-06-22 2004-08-25 �Ʒ� 非晶形药物吸附物的药物组合物
CA2457100A1 (en) * 2001-08-01 2003-02-13 Bristol-Myers Squibb Company Taste masking composition
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
ATE505183T1 (de) * 2001-10-22 2011-04-15 Taro Pharma Ind Den geschmack verdeckende auslaufsichere formulierung
EP1463440B1 (en) * 2001-12-06 2009-12-02 Duke University Prevention of flap necrosis in plastic surgery
BR0307344A (pt) * 2002-02-01 2004-12-14 Pfizer Prod Inc Composições farmacêuticas de dispersões amorfas de fármacos e materiais formadores de microfase lipofìlica
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
CN1655762B (zh) * 2002-06-17 2010-05-26 塔罗制药美国公司 布洛芬混悬剂
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
ATE421338T1 (de) * 2003-01-31 2009-02-15 Simply Thick Llc Verfahren zur herstellung verbesserter angedickter getränke gegen dysphagie
EP1653927B1 (en) * 2003-08-04 2012-01-11 Bend Research, Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
US7201920B2 (en) * 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2005105102A1 (en) * 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
WO2005123039A1 (en) 2004-06-12 2005-12-29 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
EA200701131A1 (ru) * 2004-11-24 2007-12-28 Алгоркс Фармасьютикалз, Инк. Гелеобразная препаративная форма капсаициноида и способы её применения
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8532938B2 (en) * 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US20070119928A1 (en) * 2005-11-17 2007-05-31 Jung Edward K Generating a nutraceutical request from an inventory
US20070112589A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware User interface for providing assistance related to health
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US8468029B2 (en) * 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080210748A1 (en) * 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8297028B2 (en) * 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20080004909A1 (en) * 2005-11-30 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
EP1964040A2 (en) * 2005-12-20 2008-09-03 Searete LLC. Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
CA2651855C (en) 2006-05-30 2011-08-02 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
EP2359808B1 (en) 2006-08-09 2013-05-22 Intarcia Therapeutics, Inc Osmotic delivery systems and piston assemblies
KR20080076667A (ko) 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
WO2008137181A1 (en) * 2007-05-07 2008-11-13 Clearly Superior, Inc Food thickening agent, method for producing food thickening agent
US8001345B2 (en) * 2007-05-10 2011-08-16 Dot Hill Systems Corporation Automatic triggering of backing store re-initialization
EP2170283B1 (en) 2007-06-22 2019-01-09 Board of Regents, The University of Texas System Formation of stable submicron peptide or protein particles by thin film freezing
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
EP2240155B1 (en) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Devices, formulations, and methods for delivery of multiple beneficial agents
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
EP2376522A4 (en) 2008-11-16 2013-12-25 Univ Texas LOW VISCOSIS HIGHLY CONCENTRATED SUSPENSIONS
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
EP3323423B1 (en) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Rapid establishment and/or termination of substantial steady-state drug delivery
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
PH12015501410A1 (en) 2010-12-22 2015-09-07 Purdue Pharma Lp Encased tamper resistant controlled release dosage forms
EP2654733B1 (en) 2010-12-23 2016-04-06 Purdue Pharma LP Tamper resistant solid oral dosage forms
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9370177B2 (en) 2011-12-22 2016-06-21 Babolna Bio Ltd. Consumable aqueous gel for use in pest control, a pest control device comprising an aqueous gel, and the use of an aqueous gel in a pest control device and in a method of controlling pests
EP2911530B1 (en) * 2012-10-25 2017-02-01 Nestec S.A. Encapsulated bitter peptides, methods of encapsulating bitter peptides, and nutritional compositions including encapsulated bitter peptides
US8550131B1 (en) 2013-01-02 2013-10-08 Liquid Squeeze, LLC Liquid dispensing device, system and method
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
AU2016270984B2 (en) 2015-06-03 2021-02-25 Intarcia Therapeutics, Inc. Implant placement and removal systems
EP3319596B1 (en) * 2015-07-09 2023-12-20 Uniwell Laboratories LLC Pharmaceutical compositions
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
IL307966A (en) 2017-01-03 2023-12-01 Intarcia Therapeutics Inc Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US4155741A (en) * 1974-05-01 1979-05-22 Stauffer Chemical Company Stable suspension system for microencapsulated flowable formulations, and method of preparing stable suspension of microcapsules
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4305933A (en) * 1980-03-10 1981-12-15 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4424055A (en) * 1981-12-18 1984-01-03 Herman Wesley K Irrigation and aspiration syringe
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
USRE32969E (en) * 1982-10-14 1989-06-27 Injectionable visoelastic ophthalmic gel
US4576645A (en) * 1984-12-06 1986-03-18 Block Drug Co., Inc. Whipped gel composition
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package

Also Published As

Publication number Publication date
ATE131039T1 (de) 1995-12-15
GR3018893T3 (en) 1996-05-31
TNSN91085A1 (fr) 1992-10-25
PT99143A (pt) 1993-12-31
AU8458991A (en) 1992-04-09
DE69115210T2 (de) 1996-05-09
MA22289A1 (fr) 1992-04-01
BR9104280A (pt) 1992-06-02
IL99509A (en) 1995-08-31
FI914607A0 (fi) 1991-10-01
CA2052615C (en) 2001-01-16
MY107488A (en) 1995-12-30
DE69115210D1 (de) 1996-01-18
EG19906A (fr) 1996-05-31
NO913847L (no) 1992-04-06
JPH04247023A (ja) 1992-09-03
AU643067B2 (en) 1993-11-04
JP3219799B2 (ja) 2001-10-15
US5505959A (en) 1996-04-09
IE913286A1 (en) 1992-04-08
HU219222B (en) 2001-03-28
KR920007621A (ko) 1992-05-27
RU2093143C1 (ru) 1997-10-20
CA2052615A1 (en) 1992-04-05
NO913847D0 (no) 1991-10-01
HU912990D0 (en) 1992-01-28
ZA917627B (en) 1992-06-24
EP0479005B1 (fr) 1995-12-06
KR100213513B1 (ko) 1999-08-02
NO303525B1 (no) 1998-07-27
EP0479005A1 (fr) 1992-04-08
DK0479005T3 (da) 1996-03-11
HUT59587A (en) 1992-06-29
PT99143B (pt) 1999-04-30
ES2081407T3 (es) 1996-03-01
NZ240068A (en) 1994-05-26
FI914607A (fi) 1992-04-05
DZ1530A1 (fr) 2002-02-17
IE72146B1 (en) 1997-03-26
IL99509A0 (en) 1992-08-18
US5300302A (en) 1994-04-05
FI104947B (fi) 2000-05-15

Similar Documents

Publication Publication Date Title
MX9101391A (es) Composicion farmaceutica en forma de gel,contenida dentro de un envase
MY112915A (en) Multiple unit tableted dosage form 1
GR3036622T3 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
TNSN95076A1 (fr) Forme de dosage ii d'unite multiple en comprime
EP0665733A4 (en) VAGINAL ADMINISTRATION SYSTEM USING A SPONGE.
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
IL141914A0 (en) Dosage form comprising liquid formulation
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
ES2165970T3 (es) Forma farmaceutica solida con principio activo distribuido en un material polimerico.
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
JO1880B1 (en) Format 1 for multi-unit calibration discs
JO1881B1 (en) Formula II for multi unit disc calibration
IT8223232V0 (it) Dispositivo di otturazione inviolabile in particolare per contenitori di soluzioni medicali.
FR2623173B3 (fr) Unite mobile de stockage de liquides